1Talavera K, Nilius B. Biophysics and structure-function relationship of T-type Ca^2+ channels [J]. Cell Calcium, 2006, 40: 97-114.
2Talavera K, Nilius B, Laboratorium voor F, et al. Evidence for common structural determinants of activation and inactivation in T-type Ca^2+ channels [J]. Pflugers Arch, 2006, 453: 189-201
3Zorn-Pauly K, Schaffer P, Pelzmann B, et al. L-type and T- type Ca^2+ current in cultured ventricular guinea pig myocytes [J]. PhysiolRes, 2004, 53: 369-377.
4Tanaka H, Shigenobu K. Pathophysiological significance of T-type Ca^2+ channels: T type Ca^2+ channels and drug development [J]. J Pharmacol Sci, 2005, 99: 214-220.
5Rhim H, Lee YS, Park SJ, et al. Synthesis and biological activity of 3, 4-dihydroquinazolines for selective T type Ca^2+ channel blockers [J]. Bioorg Med Chem Lett, 2005, 15: 283-286.
6Rosati B, Dun W, Hirose M, et al. Molecular basis of the T- and L-type Ca^2+ currents in canine Purkinje fibres [J]. J Physiol, 2007, 579: 465-471.
7Li M,Zhang M, Huang L, el al. T-type Ca^2+ channels are involved in high glucose-induced rat neonatal cardiomyocyte proliferation[J]. Pediatr Res, 2005, 57: 550-556.
8Danthi SJ, Enyeart JA, Enyeart JJ. Modulation of native T-type calcium channels by omega 3 fatty acids [J]. Biochem Biophys Res Commun, 2005, 327: 485-493.
9Bootman MD, Lipp P, Berridge MJJ. The organisation and functions of local Ca^2+ signals [J]. Cell Science, 2001, 114, 2213-2222.
10B'enardeau A, Weissenburger J, Hondeghem L, et al. Effects of the T-Type Ca^2+ channel blocker mibefradil on repolarization of guinea pig, rabbit, dog, monkey, and human cardiac tissue [J]. Pharmacol Exp Ther, 2000, 292: 561-575.
